Dr. Srilatha Kanumuru, MD

Dr. Kanumuru practices at University of Maryland Shore Medical Center at Easton in Easton, Maryland, part of University of Maryland Medical System.

Dr. Kanumuru's NPI, 1417985854, was assigned on June 28, 2006. Dr. Kanumuru holds Maryland license D0064539.

Dr. Kanumuru's primary practice is University of Maryland Shore Medical Center at Easton, at 219 South Washington Street, Easton, MD 21601 in Talbot County. The practice phone is (410) 822-1000.

Dr. Kanumuru's primary practice is University of Maryland Shore Medical Center at Easton in Easton, Maryland, part of University of Maryland Medical System. Dr. Kanumuru is also affiliated with University of Maryland Shore Medical Center at Chestertown. The medical group on file is Emergency Medicine Physicians (EMP).

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kanumuru practices, 2 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Kanumuru's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Kanumuru is licensed in Maryland.

CMS data shows 2,260 Medicare services from Dr. Kanumuru across 7 procedure codes in 2024, for 564 Medicare patients. Medicare paid $194,376 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 564 Medicare patients who saw Dr. Kanumuru in 2024. The largest group is 75 to 84, with 260 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 9% are also on Medicaid. Their average risk score is 2.02, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kanumuru's median patient age at 80, with 55% women.

In 2024, Dr. Kanumuru wrote 493 Medicare Part D claims for 194 patients. 88% of them were for generic drugs. CMS names the drug for 263 of them, across 13 drugs with 11 or more claims each, at $16,392 in total drug cost. In 2023, CMS named 233 claims across 12 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 22 out of 100 for Dr. Kanumuru for performance year 2024, reported individually. Dr. Kanumuru accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 7 general payments to Dr. Kanumuru from 4 drug and device companies from 2017 to 2024. Food and beverage make up the largest share, 79% of the total. Janssen Pharmaceuticals, Inc paid the most, $192.